A. Y. Arslan Et Al. , "Prevalence, determinants, and fibrosis risk stratification of metabolic-associated fatty liver disease in a Turkish primary care setting: A retrospective study.," Hepatology forum , vol.5, no.2, pp.63-67, 2023
Arslan, A. Y. Et Al. 2023. Prevalence, determinants, and fibrosis risk stratification of metabolic-associated fatty liver disease in a Turkish primary care setting: A retrospective study.. Hepatology forum , vol.5, no.2 , 63-67.
Arslan, A. Y., Celik, S., Amin, F., Caylak, I., Kesapli, I., Kilic, I. B., ... Karakullukcu, S.(2023). Prevalence, determinants, and fibrosis risk stratification of metabolic-associated fatty liver disease in a Turkish primary care setting: A retrospective study.. Hepatology forum , vol.5, no.2, 63-67.
Arslan, Ayse Et Al. "Prevalence, determinants, and fibrosis risk stratification of metabolic-associated fatty liver disease in a Turkish primary care setting: A retrospective study.," Hepatology forum , vol.5, no.2, 63-67, 2023
Arslan, Ayse Y. Et Al. "Prevalence, determinants, and fibrosis risk stratification of metabolic-associated fatty liver disease in a Turkish primary care setting: A retrospective study.." Hepatology forum , vol.5, no.2, pp.63-67, 2023
Arslan, A. Y. Et Al. (2023) . "Prevalence, determinants, and fibrosis risk stratification of metabolic-associated fatty liver disease in a Turkish primary care setting: A retrospective study.." Hepatology forum , vol.5, no.2, pp.63-67.
@article{article, author={Ayse Yazan Arslan Et Al. }, title={Prevalence, determinants, and fibrosis risk stratification of metabolic-associated fatty liver disease in a Turkish primary care setting: A retrospective study.}, journal={Hepatology forum}, year=2023, pages={63-67} }